A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...

As a prominent force in DNA sequencing and array-based technologies, Illumina has been deeply committed to China for two decades. Despite market challenges, Illumina remains steadfast in its mission ...

Illumina, Commercial Metals and Newmont have all seen broker upgrades, signaling bullish momentum amid market uncertainties.

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

ASUS Republic of Gamers (ROG) today announced that it is set to unveil the next chapter in gaming at its virtual launch event, CES 2026 ROG ? Dare to Innovate. The showcase will stream globally via ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

The disaster that struck John Quackenbush and his lab at the Harvard T.H. Chan School of Public Health began when the Trump ...

John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...